Oligometastases revisited (Q56773912)

Nature Reviews Clinical Oncology

Europe PubMed Central

title

Oligometastases revisited (English)

0 references

1

Ralph R. Weichselbaum

0 references

author name string

Samuel Hellman

series ordinal

2

0 references

language of work or name

English

0 references

publication date

22 March 2011

0 references

published in

0 references

volume

8

0 references

issue

6

0 references

page(s)

378-382

0 references

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.44

Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.44

Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.44

Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.44

Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.44

Laparoscopic Adrenalectomy for Isolated Adrenal Metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.44

Using a bigger hammer: the role of stereotactic body radiotherapy in the management of oligometastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.44

An initial report of a radiation dose-escalation trial in patients with one to five sites of metastatic disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.44

Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.44

Phase I study of individualized stereotactic body radiotherapy of liver metastases.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.44

A rationale for the targeted treatment of oligometastases with radiotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.44

Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.44

Genes that mediate breast cancer metastasis to lung

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.44

Lung metastasis genes couple breast tumor size and metastatic spread.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.44

Bone marrow cells in the 'pre-metastatic niche': within bone and beyond

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.44

RETRACTED: Lysyl oxidase is essential for hypoxia-induced metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.44

Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.44

Cetuximab and circadian chronomodulated chemotherapy as salvage treatment for metastatic colorectal cancer (mCRC): safety, efficacy and improved secondary surgical resectability.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.44

BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.44

31 March 2020

Aneuploidy and cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.44

Cancer metastasis: building a framework

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.44

Models, mechanisms and clinical evidence for cancer dormancy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.44

Metastasis: the seed and soil theory gains identity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.44

Cancer dormancy: opportunities for new therapeutic approaches

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.44

Does tumour dormancy offer a therapeutic target?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.44

Interferons, immunity and cancer immunoediting

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.44

Metastasis results from preexisting variant cells within a malignant tumor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.44

Metastatic variants are generated spontaneously at a high rate in mouse KHT tumor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.44

STAT1 pathway mediates amplification of metastatic potential and resistance to therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.44

STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.44

An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.44

Gene signatures of pulmonary metastases of renal cell carcinoma reflect the disease-free interval and the number of metastases per patient

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.44

Gene signatures of progression and metastasis in renal cell cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.44

The patterns and dynamics of genomic instability in metastatic pancreatic cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.44

Distant metastasis occurs late during the genetic evolution of pancreatic cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.44

Generation of drug-resistant variants in metastatic B16 mouse melanoma cell lines

31 March 2020

1 reference

12 December 2020

Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence

1 reference

12 December 2020

The distribution of secondary growths in cancer of the breast. 1889

1 reference

12 December 2020

Tumor heterogeneity and stability of the metastatic phenotype of mouse KHT sarcoma cells.

1 reference

12 December 2020